Equities

Fisher & Paykel Healthcare Corporation Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Fisher & Paykel Healthcare Corporation Ltd

Actions
  • Price (EUR)19.70
  • Today's Change0.00 / 0.00%
  • Shares traded101.00
  • 1 Year change+2.60%
  • Beta1.4880
Data delayed at least 15 minutes, as of Feb 10 2026 07:13 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India, and others.

  • Revenue in NZD (TTM)2.16bn
  • Net income in NZD437.00m
  • Incorporated1954
  • Employees7.51k
  • Location
    Fisher & Paykel Healthcare Corporation Ltd15 Maurice Paykel Place, East Tamaki,AUCKLAND 2013New ZealandNZL
  • Phone+64 95740100
  • Fax+64 95740158
  • Websitehttps://www.fphcare.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.